G. Facciolá
发表
A. Avenoso,
E. Spina,
I. Johansson,
1999,
Psychopharmacology.
A. Avenoso,
E. Spina,
M. G. Scordo,
2001,
Therapeutic drug monitoring.
S. Cuzzocrea,
A. De Sarro,
A. Caputi,
1997,
International journal of immunopharmacology.
A. Avenoso,
E. Spina,
M. G. Scordo,
1998
.
N. Yasui-Furukori,
E. Spina,
M. G. Scordo,
2001,
Drug metabolism and disposition: the biological fate of chemicals.
E. Perucca,
A. Avenoso,
E. Spina,
2000,
Therapeutic drug monitoring.
A. Avenoso,
G. Campo,
E. Spina,
1998,
Journal of chromatography. B, Biomedical sciences and applications.
A. Avenoso,
E. Spina,
G. Facciolá,
1999,
Therapeutic drug monitoring.
E. Perucca,
A. Avenoso,
E. Spina,
1999,
Therapeutic drug monitoring.
E. Perucca,
A. Avenoso,
E. Spina,
1998,
Therapeutic drug monitoring.
E. Perucca,
A. Avenoso,
E. Spina,
2000,
Psychopharmacology.
A. Avenoso,
E. Spina,
G. Facciolá,
2000,
Journal of chromatography. B, Biomedical sciences and applications.
A. Avenoso,
E. Spina,
M. G. Scordo,
2000,
Pharmacopsychiatry.
Interleukin-1 inhibits drinking behaviour through prostaglandins, but not by nitric oxide formation.
A. Caputi,
G. Calapai,
F. Nava,
1997,
Life sciences.
E. Perucca,
A. Avenoso,
E. Spina,
2000,
Psychopharmacology.
M. Ferlito,
E. Perucca,
A. Avenoso,
1997,
Pharmacological research.
S. Cuzzocrea,
A. De Sarro,
A. Caputi,
1997,
European journal of pharmacology.
M. Maj,
E. Perucca,
A. Avenoso,
1998,
International clinical psychopharmacology.
M. Hidestrand,
G. Tybring,
C. von Bahr,
2001,
European Journal of Clinical Pharmacology.